GALLI EO DIN 02492806
Status: Marketed
Holder: IRE ELIT S.A.
Health Canada record
| Active ingredient(s) | GALLIUM 68 Ga CHLORIDE 1.85 GBQ |
|---|
| Dosage form | Solution |
|---|
| Route | 0-Unassigned |
|---|
| Schedule | SCHEDULE C |
|---|
| Class | Radiopharmaceutical |
|---|
| ATC | V09IX OTHER DIAGNOSTIC RADIOPHARM. FOR TUMOR DETECTION |
|---|
| Original market date | 29-Jul-2020 |
|---|
| Current status date | 29-Jul-2020 |
|---|
| Source | Health Canada DPD |
|---|
Establishment licence of the holder
IRE Elit SA — licence , not currently licensed, last inspection rating C (2023-11-29).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing GALLIUM 68 Ga CHLORIDE
| DIN | Product | Company | Form | Strength | Status |
|---|
| 02503603 | GALLIAPHARM | ECKERT & ZIEGLER RADIOPHARMA GMBH | Solution | GALLIUM 68 Ga CHLORIDE 1.85 GBQ | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|
| 23094 | 2019-11-13 | New Drug Submission (NDS) | |
Request a quote for GALLI EO
How to read a Canadian DIN record